Fulgent Genetics has a low Price/Book ratio and promising drug candidates. Key trial results are expected in May 2025. Read ...

Corvus Pharmaceuticals suffered lately, especially after it announced in December 2024 its early AD data. Check out why I ...

The abstracts will be available on the AACR 2025 meeting website. The posters will be available online at Erasca.com/science/presentations following the presentations.

The Educational Choice for Children Act of 2025 would provide donors to nonprofit groups that distribute private K-12 school vouchers with a dollar-for-dollar federal tax credit in exchange for their ...

Q4 2024 Earnings Call Transcript March 25, 2025 Rumble Inc. misses on earnings expectations. Reported EPS is $-0.44 EPS, ...

On March 12, 2025, the staff of the Division of Corporation Finance at the Securities and Exchange Commission (SEC) issued a no-action letter ...

The third of four looks at how specific accounting firm niches are being impacted — for good and ill — by artificial ...

Aura Biosciences (AURA) has reported its Q4 and full-year 2024 financial results, prompting an ongoing decline in shares despite showing ...

As of the writing of this article, 24 states have legalized recreational weed in America, in addition to the District of ...

In 2024, professional and everyday investors flocked to companies enacting stock splits. Where to invest $1,000 right now? Our analyst team just revealed what they believe are the ...

Differentiated development program includes two Nkarta clinical trials and two investigator-sponsored trials of NKX019 in rheumatic and ...

In March, one insider purchased a total of $15.99 million Zymeworks shares at an average price of $12.29 per share. The stock trades at $12.96 having declined 11.48% year-to-date. However, over the ...